Drug shortage
Rifampin Capsule · Lupin Pharmaceuticals, Inc.
FDA drug shortage · Current · updated Apr 15, 2025
Key facts
| Generic name | Rifampin Capsule |
|---|---|
| Proprietary name | Rifampin |
| Company | Lupin Pharmaceuticals, Inc. |
| Presentation | Rifampin, Capsule, 300 mg (NDC 68180-659-06) |
| Dosage form | Capsule |
| Strength | 300 mg |
| Status | Current |
| Therapeutic category | Anti-Infective |
| Package NDCs | 68180-659-06 |
| First posted | Dec 22, 2021 |
| Last updated | Apr 15, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: